BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8892368)

  • 21. Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia.
    Howell DL; Lew G; Comeaux LG; Meacham LR
    Pediatr Blood Cancer; 2007 Sep; 49(3):349-52. PubMed ID: 16602119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moyamoya syndrome following childhood acute lymphoblastic leukemia.
    Kikuchi A; Maeda M; Hanada R; Okimoto Y; Ishimoto K; Kaneko T; Ikuta K; Tsuchida M;
    Pediatr Blood Cancer; 2007 Mar; 48(3):268-72. PubMed ID: 16615044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of late intensification therapy with high-dose methotrexate for standard-risk acute lymphoblastic leukemia in childhood (CCLSG-S811 study). The Children's Cancer and Leukemia Study Group.
    Koizumi S; Fujimoto T; Sasaki K; Takeda T; Utsumi J; Mimaya J; Ohta S; Ninomiya T; Takaue Y
    Int J Hematol; 1991 Aug; 54(4):307-13. PubMed ID: 1777605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia.
    Harila-Saari AH; Pääkkö EL; Vainionpää LK; Pyhtinen J; Lanning BM
    Cancer; 1998 Dec; 83(12):2608-17. PubMed ID: 9874469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia.
    Waber DP; Tarbell NJ; Kahn CM; Gelber RD; Sallan SE
    J Clin Oncol; 1992 May; 10(5):810-7. PubMed ID: 1569453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late effects among long-term survivors of childhood acute leukemia in The Netherlands: a Dutch Childhood Leukemia Study Group Report.
    van der Does-van den Berg A; de Vaan GA; van Weerden JF; Hählen K; van Weel-Sipman M; Veerman AJ
    Pediatr Res; 1995 Nov; 38(5):802-7. PubMed ID: 8552452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CNS late effects after ALL therapy in childhood. Part II: Conventional EEG recordings in asymptomatic long-term survivors of childhood ALL--an evaluation of the interferences between neurophysiology, neurology, psychology, and CNS morphology. German Late Effects Working Group.
    Ueberall MA; Wenzel D; Hertzberg H; Langer T; Meier W; Berger-Jones K; Huk WJ; Neuhäuser G; Lampert F; Beck JD; Korinthenberg R
    Med Pediatr Oncol; 1997 Aug; 29(2):121-31. PubMed ID: 9180914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols.
    Kroczka S; Stepien K; Witek-Motyl I; Kwiecinska K; Kapusta E; Biedron A; Skorek P; Skoczen S
    BMC Cancer; 2021 Feb; 21(1):150. PubMed ID: 33568096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study.
    Ochs J; Mulhern R; Fairclough D; Parvey L; Whitaker J; Ch'ien L; Mauer A; Simone J
    J Clin Oncol; 1991 Jan; 9(1):145-51. PubMed ID: 1985164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cranial irradiation does not result in pituitary-gonadal axis dysfunction in very long-term male survivors of childhood acute lymphoblastic leukemia.
    van Casteren NJ; Pieters R; Dohle GR; van Baalen M; Neggers S; van den Heuvel-Eibrink MM
    Leukemia; 2009 Dec; 23(12):2310-3. PubMed ID: 19727128
    [No Abstract]   [Full Text] [Related]  

  • 34. Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia.
    Haupt R; Fears TR; Robison LL; Mills JL; Nicholson HS; Zeltzer LK; Meadows AT; Byrne J
    JAMA; 1994 Nov; 272(18):1427-32. PubMed ID: 7933424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative EEG in long-term survivors of acute lymphoblastic leukemia.
    Ueberall MA; Haupt K; Hertzberg H; Langer T; Meier W; Huk WJ; Beck JD; Wenzel D
    Pediatr Neurol; 1996 Nov; 15(4):293-8. PubMed ID: 8972527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group.
    Hertzberg H; Huk WJ; Ueberall MA; Langer T; Meier W; Dopfer R; Skalej M; Lackner H; Bode U; Janssen G; Zintl F; Beck JD
    Med Pediatr Oncol; 1997 Jun; 28(6):387-400. PubMed ID: 9143382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children's Cancer Group.
    Glover DA; Byrne J; Mills JL; Robison LL; Nicholson HS; Meadows A; Zeltzer LK;
    J Clin Oncol; 2003 Dec; 21(23):4395-401. PubMed ID: 14645430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical activity and late effects in childhood acute lymphoblastic leukemia long-term survivors.
    Bertorello N; Manicone R; Galletto C; Barisone E; Fagioli F
    Pediatr Hematol Oncol; 2011 Aug; 28(5):354-63. PubMed ID: 21413831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer.
    Butler RW; Hill JM; Steinherz PG; Meyers PA; Finlay JL
    J Clin Oncol; 1994 Dec; 12(12):2621-9. PubMed ID: 7989937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
    Zając-Spychała O; Pawlak M; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Wachowiak J
    Leuk Lymphoma; 2018 Oct; 59(10):2342-2351. PubMed ID: 29424258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.